Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

WDR1 Recombinant Antibody, HRP Conjugated

Product Specifications

Background

Induces disassembly of actin filaments in conjunction with ADF/cofilin family proteins. Enhances cofilin-mediated actin severing.Involved in cytokinesis. Involved in chemotactic cell migration by restricting lamellipodial membrane protrusions.Involved in myocardium sarcomere organization. Required for cardiomyocyte growth and maintenance.

Synonyms

AIP1; NORI 1; wdr1.

Gene ID

9948

Swiss Prot

O75083

Host

Rabbit

Cross Reactivity

Human

Target

WDR1

Clonality

Recombinant

Isotype

IgG

Conjugation

HRP

Source

KLH conjugated synthetic peptide derived from human WDR1

Applications

WB, IHC-P, IHC-F

Purification

Purified by Protein A.

Concentration

Lot dependent

Dilution

WB (1:300-5000), IHC-P (1:200-400), IHC-F (1:100-500)

Buffer

Aqueous buffered solution containing 0.01M TBS (pH 7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol.

Modification

Unmodified

Storage Conditions

Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.

Gene ID URL

9948

Available Sizes

Curated Selection

Explore Other Products

Discover premium biology products from our extensive collection of 20M+ items

Prokaryotic Human Vascular Endothelial Growth Factor 145
RPU61776-01 50 µg

Prokaryotic Human Vascular Endothelial Growth Factor 145

Ask
View Details
Prokaryotic Human Vascular Endothelial Growth Factor 145
RPU61776-02 100 µg

Prokaryotic Human Vascular Endothelial Growth Factor 145

Ask
View Details
Prokaryotic Human Vascular Endothelial Growth Factor 145
RPU61776-03 1 mg

Prokaryotic Human Vascular Endothelial Growth Factor 145

Ask
View Details
GCP5 discontinued
536677-01 30ul

GCP5 discontinued

Ask
View Details
GCP5 discontinued
536677-02 100 µL

GCP5 discontinued

Ask
View Details
Anti-Human OLR1/LOX1 Antibody (SAA0778), PE
FHF66412 100 Tests

Anti-Human OLR1/LOX1 Antibody (SAA0778), PE

Ask
View Details